Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
After combination treatment, patients with advanced HCC exhibit different characteristics of disease progression and composition of peripheral blood immune cells. Lymph nodes and lungs were the most susceptible sites for disease progression.
Authors
- Yanan Zhao (ORCID: https://orcid.org/0000-0002-7513-0569)
- Hong-Tao Hu (ORCID: https://orcid.org/0000-0002-5432-4014)
- Quan-Jun Yao
- Di Wu (ORCID: https://orcid.org/0000-0002-6993-8350)
- Hailiang Li (ORCID: https://orcid.org/0000-0001-6454-0565)
- Hang Yuan (ORCID: https://orcid.org/0000-0001-8338-6313)
Institutions
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Central European Journal of Immunology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.5114/ceji.2024.142418
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Science and Technology Department of Henan Province